Effects of changing clinical practice on costs and outcomes of percutaneous coronary intervention between 1998 and 2002

Heart

Volumn 93, Issue 2, 2007, Pages 195-199

  Denvir, M A ^a   Lee, A J ^a   Rysdale, J ^a   Prescott, R J ^a   Eteiba, H ^b   Starkey, I R ^a   Pell, J P ^b   Walker, A ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AMBULATORY CARE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY CARE UNITS; CORONARY DISEASE; COSTS AND COST ANALYSIS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; REOPERATION; STENTS; TREATMENT OUTCOME;

EID: 33846641241     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.090134     Document Type: Article

References (19)

1. Mack MJ, Brown PP, Kugelmass AD, et al. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg 2004;77:761-6.
2. Togni M, Balmer F, Pfiffner D, et al. Working Group, Interventional Cardiology and Coronary Pathophysiology, European Society of Cardiology. Percutaneous interventions in Europe 1992-2001. Eur Heart J 2004;25:1208-13.
3. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95.
4. Betriu A, Masotti M, Serra A, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol 1999;34:1498-506.
5. Cura FA, Bhatt DL, Lincoff AM, et al. Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIA/IIIB inhibition in complex atherosclerotic lesions. Circulation 2000;102:28-34.
6. Fox KA, Mehta SR, Peters R, et al. Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8.
7. Clark MA, Bakhai A, Pelletier EM, et al. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population. Manag Care 2005;14:42-4, 46-51.
8. Cohen DJ, Baim DS. Coronary stenting: costly or cost-effective? J Invasive Cardiol 1995;7(Suppl A):36A-42A.
9. Cowper PA, Udayakumar K, Sketch MH Jr, et al. Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention. J Am Coll Cardiol 2005;45:369-76.
10. Kereiakes DJ, Obenchain RL, Barber BL, et al. Abciximab provides cost-effective survival advantage in high-volume interventional practice. Am Heart J 2000;140:603-10.
11. Denvir MA, Lee AJ, Rysdale J, et al. Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis. J Public Health (Oxf) 2004;26:177-84.
12. Plumridge N. On payment by results. Health Serv J, 2005 18, 115:15.
13. Volpp KG, Williams SV, Waldfogel J, et al. Market reform in New Jersey and the effect on mortality from acute myocardial infarction. Health Serv Res 2003;38:515-33.
14. Shmueli A, Intrator O, Israeli A. The effects of introducing prospective payments to general hospitals on length of stay, quality of care, and hospitals' income: the early experience of Israel. Soc Sci Med 2002;55:981-9
15. Scottish Health Service Costs (Year Ended 31st March 1999). Information and Statistics Division, Scottish Executive. http://www.show.scot.nhs.uk (accessed 17 Oct 2000).
16. Moscucci M, Muller DW, Watts CM, et al. Reducing costs and improving outcomes of percutaneous coronary interventions. Am J Manag Care 2003;9:365-72.
17. Jokhi PP, Critoph C, Rozkovec A, et al. Is coronary angiography in unstable patients safe in district general hospitals without any on-site revascularisation? Int J Cardiol 2005;105:147-51.
18. Leslie SJ, Henriksen PA, Timlin H, et al. Urgent in-patient coronary angiography: a comparison of centres with and without cardiac catheter facilities. Scott Med J (In press).
19. Lewis RQ. Back to the future? BMJ 2004;329:932. 199